Vasoconstrictors Flashcards

(37 cards)

1
Q

Functions of vasoconstrictors (3)

A

Prolong duration of local anesthesia
Decrease likelihood of toxicity
Provide hemostatic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Groups of vasoconstrictors (3)

A

Pyrocathetic (epi & ne)
Benzol (levo)
Phenol (phenylephrine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mode of action of vasoconstrictors

A

are direct acting agents that attach directly to adrenergic receptors to produce sympathetic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adrenergic receptor that produce vasoconstriction when stimulated

A

alpha receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adrenergic receptors that produce vasodilation when stimulated

A

beta receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

beta receptor in the heart and small intestine

A

beta 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

beta receptor in the bronchi and vascular beds

A

beta 2, for bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vasoconstrictor drugs (5)

A

Epinephrine
Norepinephrine
Levonordefrin
Phenylephrine
Felypressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the rebound activity

A

excessive bleeding following use of epinephrine, vasodilation after vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dominant effect of norepinephrine stimulates which adrenergic receptor

A

Alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dominant effect of epinephrine stimulates which adrenergic receptor

A

Equal alpha and beta

at higher dose = alpha
at lower dose = beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F. Epinephrine stimulates the CNS even below toxic levels

A

F. After toxic level is reached

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vasoconstrictor that increases blood glucose

A

Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dosage of epinephrine for healthy patients

A

0.2mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dosage of epinephrine for patients with cardiac problems

A

0.04mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dosage of norepinephrine for patients with cardiac problems

17
Q

Dosage of norepinephrine for healthy patients

18
Q

Tissue necrosis due to intense vasoconstriction

A

Ischemic effect

19
Q

Vasoconstrictor associated with ischemic effect

A

norepinephrine

20
Q

Dosage of levonordefrin for patients with cardiac problems

21
Q

Dosage of levonordefrin for healthy patients

22
Q

Dosage of phenylephrine for patients with cardiac problems

23
Q

Dosage of phenylephrine for healthy patients

24
Q

Dosage of felypressin

A

0.27 IU (9ml of 0.03 IU/ml soln)

25
Vasoconstrictor that mostly affect smaller blood vessels such as arterioles
levonordefrin
26
Vasoconstrictor associated with arteriolar constriction
levonordefrin
27
Least potent vasoconstrictor
phenylephrine
28
Most stable vasoconstrictor
phenylephrine
29
Vasoconstrictor similar to an antidiuretic hormone
felypressin
30
Nonsympathomimetic vasoconstrictor
felypressin
31
Contraindication of felypressin
preggers
32
Vasoconstrictor whose action is more pronounced in the venous microcirculation
felypressin
33
Termination of action of endogenous vasoconstrictors
reuptake in the blood stream and restorage in the adrenal medulla
34
Termination of action of exogenous vasoconstrictors (3)
1. Deactivation by extraneuronal enzymes (Catechol-O-methyl-transferase) 2. Uptake by the bloodstream 3. Intraneuronal enzymatic destruction (monoamine oxidase/MAO)
35
Selection of vasoconstrictor is based on: (2)
Duration of desired effect Physical condition of the patient
36
Potential drug interaction of vasoconstrictors (4)
1. Tricyclic antidepressants 2. MAO inhibitors (for hypertension and certain states of mental depression) 3. Alpha blockers (phenothiazine, phentolamine, -osin hypertension meds) 4. Beta blockers (-olol hypertension meds)
37
Systemic conditions that limit the use of vasoconstriction (5)
1. Thyrotoxicosis 2. Cardiovascular conditions (also a contraindication) 3. Diabetes Mellitus 4. Desire to produce hemostasis 5. Concurrent Medication